AT275733B - Verfahren zur Herstellung von monovalenten oder polyvalenten Vaccinen - Google Patents
Verfahren zur Herstellung von monovalenten oder polyvalenten VaccinenInfo
- Publication number
- AT275733B AT275733B AT1049667A AT1049667A AT275733B AT 275733 B AT275733 B AT 275733B AT 1049667 A AT1049667 A AT 1049667A AT 1049667 A AT1049667 A AT 1049667A AT 275733 B AT275733 B AT 275733B
- Authority
- AT
- Austria
- Prior art keywords
- monovalent
- production
- polyvalent vaccines
- vaccines
- polyvalent
- Prior art date
Links
- 229940031348 multivalent vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR84337A FR1538322A (fr) | 1966-11-21 | 1966-11-21 | Procédé de préparation d'une suspension virale inactivée |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT275733B true AT275733B (de) | 1969-11-10 |
Family
ID=8621311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT1049667A AT275733B (de) | 1966-11-21 | 1967-11-21 | Verfahren zur Herstellung von monovalenten oder polyvalenten Vaccinen |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3655871A (de) |
| AT (1) | AT275733B (de) |
| BE (1) | BE706781A (de) |
| CH (1) | CH477552A (de) |
| DE (1) | DE1617779A1 (de) |
| DK (1) | DK117316B (de) |
| ES (1) | ES347412A1 (de) |
| FI (1) | FI43766B (de) |
| FR (1) | FR1538322A (de) |
| GB (1) | GB1183506A (de) |
| GR (1) | GR33293B (de) |
| IL (1) | IL28977A (de) |
| NL (1) | NL6715369A (de) |
| SE (1) | SE365542B (de) |
| YU (1) | YU31920B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4158054A (en) | 1973-10-18 | 1979-06-12 | Duncan Flockhart & Co. Ltd. | Preparation of virus sub-unit vaccines |
| US4000257A (en) * | 1975-12-22 | 1976-12-28 | American Cyanamid Company | Process for the purification of influenza virus vaccine |
| US4500513A (en) * | 1979-05-15 | 1985-02-19 | Miles Laboratories, Inc. | Influenza vaccine production in liquid cell culture |
| USRE33164E (en) * | 1979-05-15 | 1990-02-13 | Mobay Corporation | Influenza vaccine production in liquid cell culture |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| US4820805A (en) * | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
| US4764369A (en) * | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
| US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
| US5639461A (en) * | 1994-09-30 | 1997-06-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Influenza machine |
| DE69525659D1 (de) * | 1995-10-20 | 2002-04-04 | Yissum Res Dev Co | Grippe-impfstoff |
| AUPQ486699A0 (en) * | 1999-12-23 | 2000-02-03 | Aruba International Pty Ltd | A method of treating infectious diseases |
| US20090017069A1 (en) | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
| US20060060520A1 (en) | 2001-06-25 | 2006-03-23 | Bomberger David C | Systems and methods using a solvent for the removal of lipids from fluids |
| US6991727B2 (en) | 2001-06-25 | 2006-01-31 | Lipid Sciences, Inc. | Hollow fiber contactor systems for removal of lipids from fluids |
| AU2002322284A1 (en) | 2001-06-25 | 2003-01-08 | Lipid Sciences, Inc. | Systems and methods using multiple solvents for the removal of lipids from fluids |
| US20030133829A1 (en) * | 2001-12-21 | 2003-07-17 | Baxter Healthcare Corporation | Process for inactivating pathogens in a biological material |
| US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US20090181362A1 (en) * | 2005-09-02 | 2009-07-16 | Yasuo Suzuki | Method for determination of recognition specificity of virus for receptor sugar chain |
| US9901631B2 (en) | 2012-01-10 | 2018-02-27 | The Broad Institute, Inc. | Method and cells for the production of viral vaccines |
-
1966
- 1966-11-21 FR FR84337A patent/FR1538322A/fr not_active Expired
-
1967
- 1967-11-13 NL NL6715369A patent/NL6715369A/xx unknown
- 1967-11-18 GR GR670133293A patent/GR33293B/el unknown
- 1967-11-20 BE BE706781D patent/BE706781A/xx unknown
- 1967-11-20 US US684540A patent/US3655871A/en not_active Expired - Lifetime
- 1967-11-20 SE SE15924/67A patent/SE365542B/xx unknown
- 1967-11-20 IL IL28977A patent/IL28977A/en unknown
- 1967-11-20 FI FI3119/67A patent/FI43766B/fi active
- 1967-11-20 DK DK579067AA patent/DK117316B/da unknown
- 1967-11-20 YU YU2268/67A patent/YU31920B/xx unknown
- 1967-11-20 GB GB52684/67A patent/GB1183506A/en not_active Expired
- 1967-11-21 CH CH1626667A patent/CH477552A/fr not_active IP Right Cessation
- 1967-11-21 AT AT1049667A patent/AT275733B/de active
- 1967-11-21 DE DE19671617779 patent/DE1617779A1/de active Pending
- 1967-11-21 ES ES347412A patent/ES347412A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES347412A1 (es) | 1969-01-16 |
| DK117316B (da) | 1970-04-13 |
| SE365542B (de) | 1974-03-25 |
| CH477552A (fr) | 1969-08-31 |
| NL6715369A (de) | 1968-05-22 |
| DE1617779A1 (de) | 1972-03-23 |
| US3655871A (en) | 1972-04-11 |
| GR33293B (el) | 1967-11-21 |
| BE706781A (de) | 1968-05-20 |
| FR1538322A (fr) | 1968-09-06 |
| IL28977A (en) | 1972-05-30 |
| YU31920B (en) | 1974-02-28 |
| GB1183506A (en) | 1970-03-11 |
| FI43766B (de) | 1971-03-01 |
| YU226867A (en) | 1973-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH501580A (de) | Verfahren zur Herstellung von tertiären Aminen | |
| CH490089A (de) | Verfahren zur Herstellung von Hydrotalcit | |
| AT275733B (de) | Verfahren zur Herstellung von monovalenten oder polyvalenten Vaccinen | |
| AT263734B (de) | Verfahren zur Herstellung von Diolefinen | |
| AT285169B (de) | Verfahren zur Herstellung von Organopolysiloxanen | |
| AT277947B (de) | Verfahren zur Herstellung von Monoolefinen | |
| CH476041A (de) | Verfahren zur Herstellung von Latices | |
| AT282321B (de) | Verfahren zur Herstellung von Marfarinefett | |
| CH480304A (de) | Verfahren zur Herstellung von schwefelhaltigen Aminen | |
| CH490412A (de) | Verfahren zur Herstellung von cyclischen Thioimidaten | |
| CH487167A (de) | Verfahren zur Herstellung von Pyrazinoylguanidinen oder Pyrazinamidoguanidinen | |
| AT286247B (de) | Verfahren zur Herstellung von Mono-Olefinen | |
| CH487169A (de) | Verfahren zur Herstellung von Pyrazinoylguanidinen oder Pyrazinamidoguanidinen | |
| CH479626A (de) | Verfahren zur Herstellung von Organooxysilanen | |
| AT266810B (de) | Verfahren zur Herstellung von ɛ-Caprolacton | |
| CH487128A (de) | Verfahren zur Herstellung von N-Carbamoyloxyphenylcarbamaten | |
| AT274759B (de) | Verfahren zur Herstellung von Glycid | |
| CH472381A (de) | Verfahren zur Herstellung von Monohalogeno- azeto-azetamiden | |
| CH483388A (de) | Verfahren zur Herstellung von Tritylaminen | |
| CH444132A (de) | Verfahren zur Herstellung von Mannit | |
| AT265223B (de) | Verfahren zur kontinuierlichen Herstellung von Dibrombutenen | |
| CH479555A (de) | Verfahren zur kontinuierlichen Herstellung von Tetrachlor-o-phthalodinitril | |
| AT277957B (de) | Verfahren zur Herstellung von Alkenonen | |
| CH477470A (de) | Verfahren zur Herstellung von Ribofuranosiden | |
| AT270068B (de) | Verfahren zur Herstellung von Anti-Rh-γ-Globulin |